about
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancerNetwork-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer RiskStathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancerCyclic AMP induces IPC leukemia cell apoptosis via CRE-and CDK-dependent Bim transcriptionNo clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.Switch in FOXA1 status associates with endometrial cancer progressionThe progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling.High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors.Landscape of genomic alterations in cervical carcinomas.Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancerConsortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.High-throughput mutation profiling of primary and metastatic endometrial cancers identifies KRAS, FGFR2 and PIK3CA to be frequently mutatedIntegrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.Introduction of aromatic ring-containing substituents in cyclic nucleotides is associated with inhibition of toxin uptake by the hepatocyte transporters OATP 1B1 and 1B3.cAMP effector mechanisms. Novel twists for an 'old' signaling system.Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients.Identification of six new susceptibility loci for invasive epithelial ovarian cancer.Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) RiskMultimodal Imaging of Orthotopic Mouse Model of Endometrial Carcinoma.Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancerLoss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcomeGenome-wide association study identifies a possible susceptibility locus for endometrial cancerPTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients.Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer.ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma.KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer.Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) RiskCommon Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC).Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.Polymorphisms in inflammation pathway genes and endometrial cancer riskGWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancerEvaluating the ovarian cancer gonadotropin hypothesis: a candidate gene studyIdentification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis.Increased microvascular permeability in mice lacking Epac1 (Rapgef3).Androgen receptor as potential therapeutic target in metastatic endometrial cancer.Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.Aneuploidy related transcriptional changes in endometrial cancer link low expression of chromosome 15q genes to poor survival.
P50
Q24633316-D49EED38-58F2-404A-9F97-67E27DE9EA89Q26799669-9AFA6C08-2B31-4E6B-BA3C-562B55287936Q27852937-266BEBA9-19DD-4512-8EDD-FE17717C0A48Q28580418-3452141A-6A5D-43DC-9E4A-7F490DC0C112Q30374367-F7591C3A-41FE-460C-98D3-0FAF3E428C89Q33572253-800F19DE-B992-4C09-BE3F-F47201D29603Q33645463-D972FA0C-CC9E-4A27-A130-206D51F7A532Q33704281-EFF83018-CFC0-47D7-BF97-091B8A2B3501Q33877440-426A1968-9700-4A95-AC14-7A2E6EBF51A9Q34169464-F8CDCDAA-1614-4DE7-9070-199158CFE772Q34310001-1C49408E-7C05-4F11-AEEF-0012E9777713Q34342248-7FC383BE-35A2-471A-A9B9-C0647DA8563BQ34541232-636B6BB4-6DF4-421F-B43F-18EB548AB752Q34580883-BAD6226B-7AAE-4A6B-9CFC-AD1921C0542DQ35150765-21064564-97F0-4DE3-8B5B-0B88E26085D9Q35163972-8478D28D-1957-4842-8949-0C6DA4FA2AFCQ35176084-92E488B3-E9AE-4B0D-B473-7343349E0936Q35541663-288CB9BC-729A-49EE-B6CE-18892D7E0836Q35668946-36EF0874-BDE1-4FA1-8576-A16DEB46EF83Q35740059-8EEADB51-B81C-4B30-9AA0-54B15F6F09BEQ35782435-0C120607-41D9-4C0C-B8BB-DFC34F95E1C8Q35949565-96CC01BC-30FB-4C14-84C9-27F0B9A0973CQ36024614-62A97D21-2391-4D37-9F9E-DAD7D4AB2FFDQ36096004-B60996DE-1D61-4BB4-9D74-278B47D7012DQ36255665-6AFCDD12-66B7-415B-8377-6EB5E7E35B07Q36414073-D8B2AE5F-9A96-41FA-B866-6DA7973C2B7DQ36451726-6DB428C9-6D78-4BE3-9F9E-43EABDF0FD86Q36487146-C715A932-8486-48A2-BABD-67912924D1CCQ36490507-AC0557F8-42A2-497B-BB5F-2B2154B40F3EQ36897003-4736E60F-16C3-417D-AEF2-62ADB49CF0FCQ36915870-39E09BD0-BC8C-4A12-A4D1-3BDF0BF75151Q36956156-EBC973B5-9E27-44A1-A0DF-690B52EA6C25Q36966218-0700C08F-F681-4A3D-92AC-2D5076939C56Q37006170-7B353DD1-30D7-4BF6-99C9-C10BCD62BD8AQ37131530-84E77EDD-C2A1-466D-8800-237A591FB263Q37354927-AF8B8950-2990-433D-893E-0B92DAB183A9Q37580217-1E91CEB3-DDA1-45E6-A32C-3ECE4074C72CQ37624504-38C39C39-05D3-4AD9-8DB3-75B3D5DBFFA0Q37684409-32C359A7-BBB2-4E4F-A51E-F292C0C31AE5Q37706048-15D95544-1FF1-49A9-8A65-884A6A79EC6A
P50
description
Noors onderzoekster
@nl
hulumtuese
@sq
researcher
@en
հետազոտող
@hy
name
Camilla Krakstad
@ast
Camilla Krakstad
@en
Camilla Krakstad
@es
Camilla Krakstad
@nl
Camilla Krakstad
@sl
type
label
Camilla Krakstad
@ast
Camilla Krakstad
@en
Camilla Krakstad
@es
Camilla Krakstad
@nl
Camilla Krakstad
@sl
prefLabel
Camilla Krakstad
@ast
Camilla Krakstad
@en
Camilla Krakstad
@es
Camilla Krakstad
@nl
Camilla Krakstad
@sl
P106
P21
P27
P31
P496
0000-0002-0174-8139